Sonic Incytes Medical Corp.

📍 Vancouver, Canada🗓 Founded 2017👥 30 employees💰 Last funded Sep 2025
Medical Equipment Manufacturing🌐 sonicincytes.com
Website LinkedIn
Sonic Incytes is committed to enhancing patient care through innovative diagnostic solutions. The companys flagship product, Velacur™, equips physicians with an advanced liver imaging tool to help manage the growing epidemic of fatty liver disease. Velacur offers real-time, AI guided quantification of the two key markers for fatty liver disease: liver stiffness and attenuation. With real-time results, a low up-front cost and AI guidance, VELACUR makes liver imaging at the point of care affordable and accessible.
5
Total investors
1
Early stage
3
Mid stage
1
Late stage
2017
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Canada
3
United States
2
Investor activity2018–2025 · investors recorded per year
20181202012021220251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Sonic Incytes Medical Corp.?
Sonic Incytes Medical Corp. has 5 investors on record on gritt.io, including 1 early-stage backers, 3 mid-stage and 1 late-stage investors.
When did Sonic Incytes Medical Corp. last raise funding?
The most recent investment in Sonic Incytes Medical Corp. recorded on gritt.io was in September 2025.
When was Sonic Incytes Medical Corp. founded?
Sonic Incytes Medical Corp. was founded in 2017.
What industry is Sonic Incytes Medical Corp. in?
Sonic Incytes Medical Corp. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Sonic Incytes Medical Corp. based?
Sonic Incytes Medical Corp. is headquartered in Vancouver, Canada.